Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Aroda VR … Rosenstock J Journal: The Lancet Published: 2026-06-20 DOI: https://doi.org/10.1016/S0140-6736(26)00802-0